Globe News Wire
17 Apr 2026, 01:15 UTC · 22w ago
Verdict
Headline takes no side. We score ALMR +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Alamar Biosciences has priced an upsized IPO of 11,250,000 shares at $17.00 per share.
More positive than 78% of claims this week
The company expects to raise approximately $191.3 million in gross proceeds from the offering.
So whatA significant cash infusion provides the necessary runway for a life sciences company to fund R&D and commercialize its proteomics platform.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 64% of claims this week
Alamar Biosciences shares are expected to begin trading on the Nasdaq Global Select Market on April 17, 2026, under the ticker 'ALMR'.
More positive than 43% of claims this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company is pricing an upsized initial public offering, indicating strong investor demand and capital growth.
More positive than 47% of ticker scores this week
Acting as a joint book-running manager for the IPO, which generates underwriting fees.
More positive than 47% of ticker scores this week
Acting as a joint book-running manager for the IPO, which generates underwriting fees.
More positive than 47% of ticker scores this week
Acting as a joint book-running manager for the IPO, which generates underwriting fees.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Reuters
4h ago
More positive than 13% of relationship scores this week
[a_to_b] BofA Securities is acting as a joint book-running manager for Alamar Biosciences' initial public offering.
More positive than 13% of relationship scores this week
[a_to_b] J.P. Morgan is acting as a joint book-running manager for Alamar Biosciences' initial public offering.
—
No price for ALMR right now — the quote feed didn't answer.
ALMR chart →
